Korean J Gastroenterol.  2020 Jun;75(6):314-321. 10.4166/kjg.2020.75.6.314.

Post-colonoscopy Colorectal Cancer: Causes and Prevention of Interval Colorectal Cancer

• Lee JY
• Lee JH

• KMID: 2504373
• DOI: http://doi.org/10.4166/kjg.2020.75.6.314

Abstract

Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the fourth leading cause of cancer death in the worldwide. Colonoscopy is the gold standard for screening and surveillance of CRC. Removing adenomas by colonoscopy has lowered the incidence and mortality of CRC. However, colonoscopy is imperfect for detection of colorectal neoplasia. After a colonoscopy that is negative for malignancy, CRC can be diagnosed. These are termed as post-colonoscopy CRC (PCCRC). The proportion of PCCRC, among all CRC was reported to be 1.8% to 9.0%. It occurred 2.4 times more in the right colon than in the left colon. The causes of PCCRC are missed lesions, incomplete resection, and new lesions. Among these causes, missed lesion and incomplete resection are procedural factors and preventable. Therefore, it is necessary to improve the quality of colonoscopy to minimize the occurrence of PCCRC.

Keyword

Colorectal neoplasms; Colonoscopy

Figure

• 

  Fig. 1 Subcategories and potential explanations of post-colonoscopy colorectal cancer.

Reference

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018; Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. DOI: 10.3322/caac.21492. PMID: 30207593.

2. 2019. Sep. 23. Causes of Death Statistics in 2018. [Internet]. KOrean Statistical Information Service;Daejeon: Available from: http://www.index.go.kr/potal/main/EachDtlPageDetail.do?.idx_cd=2770. cited 2020 May 8.

3. Winawer SJ, Zauber AG, Ho MN, et al. 1993; Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 329:1977–1981. DOI: 10.1056/NEJM199312303292701. PMID: 8247072.

4. Zauber AG, Winawer SJ, O'Brien MJ, et al. 2012; Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 366:687–696. DOI: 10.1056/NEJMoa1100370. PMID: 22356322. PMCID: PMC3322371.

5. Doubeni CA, Corley DA, Quinn VP, et al. 2018; Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. 67:291–298. DOI: 10.1136/gutjnl-2016-312712. PMID: 27733426. PMCID: PMC5868294.

6. Rabeneck L, Paszat LF, Saskin R, Stukel TA. 2010; Association between colonoscopy rates and colorectal cancer mortality. Am J Gastroenterol. 105:1627–1632. DOI: 10.1038/ajg.2010.83. PMID: 20197758.

7. Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M. , Italian Multicentre Study Group. 2001; Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 48:812–815. DOI: 10.1136/gut.48.6.812. PMID: 11358901. PMCID: PMC1728339.

8. Schoenfeld P, Cash B, Flood A, et al. 2005; Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med. 352:2061–2068. DOI: 10.1056/NEJMoa042990. PMID: 15901859.

9. Levin B, Lieberman DA, McFarland B, et al. 2008; Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 134:1570–1595. DOI: 10.1053/j.gastro.2008.02.002. PMID: 18384785.

10. Schreuders EH, Ruco A, Rabeneck L, et al. 2015; Colorectal cancer screening: a global overview of existing programmes. Gut. 64:1637–1649. DOI: 10.1136/gutjnl-2014-309086. PMID: 26041752.

11. Jacob BJ, Moineddin R, Sutradhar R, Baxter NN, Urbach DR. 2012; Effect of colonoscopy on colorectal cancer incidence and mortality: an instrumental variable analysis. Gastrointest Endosc. 76:355–364.e1. DOI: 10.1016/j.gie.2012.03.247. PMID: 22658386.

12. Robertson DJ, Greenberg ER, Beach M, et al. 2005; Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology. 129:34–41. DOI: 10.1053/j.gastro.2005.05.012. PMID: 16012932.

13. Singh H, Turner D, Xue L, Targownik LE, Bernstein CN. 2006; Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA. 295:2366–2373. DOI: 10.1001/jama.295.20.2366. PMID: 16720822.

14. Haseman JH, Lemmel GT, Rahmani EY, Rex DK. 1997; Failure of colonoscopy to detect colorectal cancer: evaluation of 47 cases in 20 hospitals. Gastrointest Endosc. 45:451–455. DOI: 10.1016/S0016-5107(97)70172-X. PMID: 9199899.

15. Arain MA, Sawhney M, Sheikh S, et al. 2010; CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol. 105:1189–1195. DOI: 10.1038/ajg.2009.699. PMID: 20010923.

16. Singh H, Nugent Z, Demers AA, Bernstein CN. 2010; Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol. 105:2588–2596. DOI: 10.1038/ajg.2010.390. PMID: 20877348.

17. Cooper GS, Xu F, Barnholtz Sloan JS, Schluchter MD, Koroukian SM. 2012; Prevalence and predictors of interval colorectal cancers in medicare beneficiaries. Cancer. 118:3044–3052. DOI: 10.1002/cncr.26602. PMID: 21989586. PMCID: PMC3258472.

18. Samadder NJ, Curtin K, Tuohy TM, et al. 2014; Characteristics of missed or interval colorectal cancer and patient survival: a population-based study. Gastroenterology. 146:950–960. DOI: 10.1053/j.gastro.2014.01.013. PMID: 24417818.

19. Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. 2007; Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology. 132:96–102. DOI: 10.1053/j.gastro.2006.10.027. PMID: 17241863.

20. Corley DA, Jensen CD, Marks AR, et al. 2014; Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 370:1298–1306. DOI: 10.1056/NEJMoa1309086. PMID: 24693890. PMCID: PMC4036494.

21. Baxter NN, Sutradhar R, Forbes SS, Paszat LF, Saskin R, Rabeneck L. 2011; Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology. 140:65–72. DOI: 10.1053/j.gastro.2010.09.006. PMID: 20854818.

22. Erichsen R, Baron JA, Stoffel EM, Laurberg S, Sandler RS, Sørensen HT. 2013; Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study. Am J Gastroenterol. 108:1332–1340. DOI: 10.1038/ajg.2013.175. PMID: 23774154.

23. le Clercq CM, Bouwens MW, Rondagh EJ, et al. 2014; Postcolonoscopy colorectal cancers are preventable: a population-based study. Gut. 63:957–963. DOI: 10.1136/gutjnl-2013-304880. PMID: 23744612.

24. Ferrández A, Navarro M, Díez M, et al. 2010; Risk factors for advanced lesions undetected at prior colonoscopy: not always poor preparation. Endoscopy. 42:1071–1076. DOI: 10.1055/s-0030-1255868. PMID: 20960390.

25. Brenner H, Chang-Claude J, Seiler CM, Hoffmeister M. 2012; Interval cancers after negative colonoscopy: population-based case-con-trol study. Gut. 61:1576–1582. DOI: 10.1136/gutjnl-2011-301531. PMID: 22200840.

26. Kim CJ, Jung YS, Park JH, et al. 2013; Prevalence, clinicopathologic characteristics, and predictors of interval colorectal cancers in Korean population. Intest Res. 11:178–183. DOI: 10.5217/ir.2013.11.3.178.

27. Teixeira C, Martins C, Dantas E, et al. 2019; Interval colorectal cancer after colonoscopy. Rev Gastroenterol Mex. 84:284–289. DOI: 10.1016/j.rgmxen.2018.04.008. PMID: 30107945.

28. Schoen RE, Pinsky PF, Weissfeld JL, et al. 2012; Colorectal cancers not detected by screening flexible sigmoidoscopy in the prostate, lung, colorectal, and ovarian cancer screening trial. Gastrointest Endosc. 75:612–620. DOI: 10.1016/j.gie.2011.10.024. PMID: 22341106.

29. van Roon AH, Goede SL, van Ballegooijen M, et al. 2013; Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut. 62:409–415. DOI: 10.1136/gutjnl-2011-301583. PMID: 22387523.

30. Sanduleanu S, le Clercq CM, Dekker E, et al. 2015; Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature. Gut. 64:1257–1267. DOI: 10.1136/gutjnl-2014-307992. PMID: 25193802.

31. Rutter MD, Beintaris I, Valori R, et al. 2018; World endoscopy organization consensus statements on post-colonoscopy and post-imaging colorectal cancer. Gastroenterology. 155:909–925.e3. DOI: 10.1053/j.gastro.2018.05.038. PMID: 29958856.

32. Hong SN, Yang DH, Kim YH, et al. 2012; Korean guidelines for post-polypectomy colonoscopic surveillance. Korean J Gastroenterol. 59:99–117. DOI: 10.4166/kjg.2012.59.2.99. PMID: 22387835.

33. Singh S, Singh PP, Murad MH, Singh H, Samadder NJ. 2014; Prevalence, risk factors, and outcomes of interval colorectal cancers: a systematic review and meta-analysis. Am J Gastroenterol. 109:1375–1389. DOI: 10.1038/ajg.2014.171. PMID: 24957158.

34. Rex DK, Cutler CS, Lemmel GT, et al. 1997; Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 112:24–28. DOI: 10.1016/S0016-5085(97)70214-2. PMID: 8978338.

35. Zhao S, Wang S, Pan P, et al. 2019; Magnitude, risk factors, and factors associated with adenoma miss rate of tandem colonoscopy: a systematic review and meta-analysis. Gastroenterology. 156:1661–1674. e11. DOI: 10.1053/j.gastro.2019.01.260. PMID: 30738046.

36. Heresbach D, Barrioz T, Lapalus MG, et al. 2008; Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies. Endoscopy. 40:284–290. DOI: 10.1055/s-2007-995618. PMID: 18389446.

37. Xiang L, Zhan Q, Zhao XH, et al. 2014; Risk factors associated with missed colorectal flat adenoma: a multicenter retrospective tandem colonoscopy study. World J Gastroenterol. 20:10927–10937. DOI: 10.3748/wjg.v20.i31.10927. PMID: 25152596. PMCID: PMC4138473.

38. Robertson DJ, Lieberman DA, Winawer SJ, et al. 2014; Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut. 63:949–956. DOI: 10.1136/gutjnl-2012-303796. PMID: 23793224. PMCID: PMC4383397.

39. Pohl H, Srivastava A, Bensen SP, et al. 2013; Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology. 144:74–80.e1. DOI: 10.1053/j.gastro.2012.09.043. PMID: 23022496.

40. Ferlitsch M, Moss A, Hassan C, et al. 2017; Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 49:270–297. DOI: 10.1055/s-0043-102569. PMID: 28212588.

41. Matsuura N, Takeuchi Y, Yamashina T, et al. 2017; Incomplete resection rate of cold snare polypectomy: a prospective single-arm observational study. Endoscopy. 49:251–257. DOI: 10.1055/s-0043-100215. PMID: 28192823.

42. Papastergiou V, Paraskeva KD, Fragaki M, et al. 2018; Cold versus hot endoscopic mucosal resection for nonpedunculated colorectal polyps sized 6-10 mm: a randomized trial. Endoscopy. 50:403–411. DOI: 10.1055/s-0043-118594. PMID: 28898922.

43. Kuntz KM, Lansdorp-Vogelaar I, Rutter CM, et al. 2011; A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression. Med Decis Making. 31:530–539. DOI: 10.1177/0272989X11408730. PMID: 21673186. PMCID: PMC3424513.

44. Brenner H, Altenhofen L, Stock C, Hoffmeister M. 2013; Natural history of colorectal adenomas: birth cohort analysis among 3..6 million participants of screening colonoscopy. Cancer Epidemiol Biomarkers Prev. 22:1043–1051. DOI: 10.1158/1055-9965.EPI-13-0162. PMID: 23632815.

45. Markowitz SD, Bertagnolli MM. 2009; Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med. 361:2449–2460. DOI: 10.1056/NEJMra0804588. PMID: 20018966. PMCID: PMC2843693.

46. Pritchard CC, Grady WM. 2011; Colorectal cancer molecular biology moves into clinical practice. Gut. 60:116–129. DOI: 10.1136/gut.2009.206250. PMID: 20921207. PMCID: PMC3006043.

47. Hawkins N, Norrie M, Cheong K, et al. 2002; CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology. 122:1376–1387. DOI: 10.1053/gast.2002.32997. PMID: 11984524.

48. Sawhney MS, Farrar WD, Gudiseva S, et al. 2006; Microsatellite instability in interval colon cancers. Gastroenterology. 131:1700–1705. DOI: 10.1053/j.gastro.2006.10.022. PMID: 17087932.

49. Shaukat A, Arain M, Thaygarajan B, Bond JH, Sawhney M. 2010; Is BRAF mutation associated with interval colorectal cancers? Dig Dis Sci. 55:2352–2356. DOI: 10.1007/s10620-010-1182-9. PMID: 20300843.

50. Shaukat A, Arain M, Anway R, Manaktala S, Pohlman L, Thyagarajan B. 2012; Is KRAS mutation associated with interval colorectal cancers? Dig Dis Sci. 57:913–917. DOI: 10.1007/s10620-011-1974-6. PMID: 22138963.

51. Luo Y, Wong CJ, Kaz AM, et al. 2014; Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 147:418–429.e8. DOI: 10.1053/j.gastro.2014.04.039. PMID: 24793120. PMCID: PMC4107146.

52. Chan AO, Issa JP, Morris JS, Hamilton SR, Rashid A. 2002; Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol. 160:529–536. DOI: 10.1016/S0002-9440(10)64872-9. PMID: 11839573. PMCID: PMC1850645.

53. Wynter CV, Walsh MD, Higuchi T, Leggett BA, Young J, Jass JR. 2004; Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer. Gut. 53:573–580. DOI: 10.1136/gut.2003.030841. PMID: 15016754. PMCID: PMC1774017.

54. Chokshi RV, Hovis CE, Hollander T, Early DS, Wang JS. 2012; Prevalence of missed adenomas in patients with inadequate bowel preparation on screening colonoscopy. Gastrointest Endosc. 75:1197–1203. DOI: 10.1016/j.gie.2012.01.005. PMID: 22381531.

55. Chang JY, Moon CM, Lee HJ, et al. 2018; Predictive factors for missed adenoma on repeat colonoscopy in patients with suboptimal bowel preparation on initial colonoscopy: a KASID multicenter study. PLoS One. 13:e0195709. DOI: 10.1371/journal.pone.0195709. PMID: 29698398. PMCID: PMC5919514.

56. Kluge MA, Williams JL, Wu CK, et al. 2018; Inadequate Boston bowel preparation scale scores predict the risk of missed neoplasia on the next colonoscopy. Gastrointest Endosc. 87:744–751. DOI: 10.1016/j.gie.2017.06.012. PMID: 28648575. PMCID: PMC5742069.

57. Radaelli F, Paggi S, Hassan C, et al. 2017; Split-dose preparation for colonoscopy increases adenoma detection rate: a randomised controlled trial in an organised screening programme. Gut. 66:270–277. DOI: 10.1136/gutjnl-2015-310685. PMID: 26657900.

58. Martel M, Barkun AN, Menard C, Restellini S, Kherad O, Vanasse A. 2015; Split-dose preparations are superior to day-before bowel cleansing regimens: a meta-analysis. Gastroenterology. 149:79–88. DOI: 10.1053/j.gastro.2015.04.004. PMID: 25863216.

59. Johnson DA, Barkun AN, Cohen LB, et al. 2014; Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US multi-society task force on colorectal cancer. Gastroenterology. 147:903–924. DOI: 10.1053/j.gastro.2014.07.002. PMID: 25239068.

60. Hassan C, East J, Radaelli F, et al. 2019; Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline - update 2019. Endoscopy. 51:775–794. DOI: 10.1055/a-0959-0505. PMID: 31295746.

61. Spiegel BM, Talley J, Shekelle P, et al. 2011; Development and validation of a novel patient educational booklet to enhance colonoscopy preparation. Am J Gastroenterol. 106:875–883. DOI: 10.1038/ajg.2011.75. PMID: 21483463.

62. Lorenzo-Zúñiga V, Moreno de Vega V, Marín I, Barberá M, Boix J. 2015; Improving the quality of colonoscopy bowel preparation using a smart phone application: a randomized trial. Dig Endosc. 27:590–595. DOI: 10.1111/den.12467. PMID: 25708251.

63. Romero RV, Mahadeva S. 2013; Factors influencing quality of bowel preparation for colonoscopy. World J Gastrointest Endosc. 5:39–46. DOI: 10.4253/wjge.v5.i2.39. PMID: 23424015. PMCID: PMC3574611.

64. Hassan C, Fuccio L, Bruno M, et al. 2012; A predictive model identifies patients most likely to have inadequate bowel preparation for colonoscopy. Clin Gastroenterol Hepatol. 10:501–506. DOI: 10.1016/j.cgh.2011.12.037. PMID: 22239959.

65. Kaminski MF, Thomas-Gibson S, Bugajski M, et al. 2017; Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. Endoscopy. 49:378–397. DOI: 10.1055/s-0043-103411. PMID: 28268235.

66. Rex DK, Schoenfeld PS, Cohen J, et al. 2015; Quality indicators for colonoscopy. Am J Gastroenterol. 110:72–90. DOI: 10.1038/ajg.2014.385. PMID: 25448873.

67. Kaminski MF, Regula J, Kraszewska E, et al. 2010; Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 362:1795–1803. DOI: 10.1056/NEJMoa0907667. PMID: 20463339.

68. Zorzi M, Senore C, Da Re F, et al. 2017; Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy). Gut. 66:1233–1240. DOI: 10.1136/gutjnl-2015-310587. PMID: 26896459.

69. Rex DK, Boland CR, Dominitz JA, et al. 2017; Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 86:18–33. DOI: 10.1016/j.gie.2017.04.003. PMID: 28600070.

70. Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. 2006; Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med. 355:2533–2541. DOI: 10.1056/NEJMoa055498. PMID: 17167136.

71. Shaukat A, Rector TS, Church TR, et al. 2015; Longer withdrawal time is associated with a reduced incidence of interval cancer after screening colonoscopy. Gastroenterology. 149:952–957. DOI: 10.1053/j.gastro.2015.06.044. PMID: 26164494.

72. Moss A, Williams SJ, Hourigan LF, et al. 2015; Long-term adenoma recurrence following wide-field endoscopic mucosal resection (WF-EMR) for advanced colonic mucosal neoplasia is infrequent: results and risk factors in 1000 cases from the Australian Colonic EMR (ACE) study. Gut. 64:57–65. DOI: 10.1136/gutjnl-2013-305516. PMID: 24986245.

73. Buchner AM, Guarner-Argente C, Ginsberg GG. 2012; Outcomes of EMR of defiant colorectal lesions directed to an endoscopy referral center. Gastrointest Endosc. 76:255–263. DOI: 10.1016/j.gie.2012.02.060. PMID: 22657404.

74. Lee EJ, Lee JB, Lee SH, Youk EG. 2012; Endoscopic treatment of large colorectal tumors: comparison of endoscopic mucosal resection, endoscopic mucosal resection-precutting, and endoscopic submucosal dissection. Surg Endosc. 26:2220–2230. DOI: 10.1007/s00464-012-2164-0. PMID: 22278105.

75. Longcroft-Wheaton G, Duku M, Mead R, Basford P, Bhandari P. 2013; Risk stratification system for evaluation of complex polyps can predict outcomes of endoscopic mucosal resection. Dis Colon Rectum. 56:960–966. DOI: 10.1097/DCR.0b013e31829193e0. PMID: 23838864.

76. Yoshida N, Naito Y, Kugai M, et al. 2011; Efficacy of magnifying endoscopy with flexible spectral imaging color enhancement in the diagnosis of colorectal tumors. J Gastroenterol. 46:65–72. DOI: 10.1007/s00535-010-0339-9. PMID: 21061025.

77. Sano Y, Tanaka S, Kudo SE, et al. 2016; Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI expert team. Dig Endosc. 28:526–533. DOI: 10.1111/den.12644. PMID: 26927367.

78. Ikematsu H, Matsuda T, Emura F, et al. 2010; Efficacy of capillary pattern type IIIA/IIIB by magnifying narrow band imaging for estimating depth of invasion of early colorectal neoplasms. BMC Gastroenterol. 10:33. DOI: 10.1186/1471-230X-10-33. PMID: 20346170. PMCID: PMC2868042.

79. Hayashi N, Tanaka S, Hewett DG, et al. 2013; Endoscopic prediction of deep submucosal invasive carcinoma: validation of the narrow-band imaging international colorectal endoscopic (NICE) classification. Gastrointest Endosc. 78:625–632. DOI: 10.1016/j.gie.2013.04.185. PMID: 23910062.

80. Kudo S, Hirota S, Nakajima T, et al. 1994; Colorectal tumours and pit pattern. J Clin Pathol. 47:880–885. DOI: 10.1136/jcp.47.10.880. PMID: 7962600. PMCID: PMC502170.

81. Hurlstone DP, Cross SS, Adam I, et al. 2004; Endoscopic morphological anticipation of submucosal invasion in flat and depressed colorectal lesions: clinical implications and subtype analysis of the kudo type V pit pattern using high‐magnification‐chromoscopic colonoscopy. Colorectal Dis. 6:369–375. DOI: 10.1111/j.1463-1318.2004.00667.x. PMID: 15335372.

82. Tobaru T, Mitsuyama K, Tsuruta O, Kawano H, Sata M. 2008; Sub-classification of type VI pit patterns in colorectal tumors: relation to the depth of tumor invasion. Int J Oncol. 33:503–508. PMID: 18695879.

83. Li M, Ali SM, Umma-OmarahGilani S, Liu J, Li YQ, Zuo XL. 2014; Kudo's pit pattern classification for colorectal neoplasms: a meta-analysis. World J Gastroenterol. 20:12649–12656. DOI: 10.3748/wjg.v20.i35.12649. PMID: 25253970. PMCID: PMC4168103.

84. Gono K, Obi T, Yamaguchi M, et al. 2004; Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt. 9:568–577. DOI: 10.1117/1.1695563. PMID: 15189095.

85. Kaltenbach T, Friedland S, Soetikno R. 2008; A randomised tandem colonoscopy trial of narrow band imaging versus white light examination to compare neoplasia miss rates. Gut. 57:1406–1412. DOI: 10.1136/gut.2007.137984. PMID: 18523025.

86. Paggi S, Radaelli F, Amato A, et al. 2009; The impact of narrow band imaging in screening colonoscopy: a randomized controlled trial. Clin Gastroenterol Hepatol. 7:1049–1054. DOI: 10.1016/j.cgh.2009.06.028. PMID: 19577008.

87. Atkinson NSS, Ket S, Bassett P, et al. 2019; Narrow-Band Imaging for Detection of Neoplasia at Colonoscopy: A Meta-analysis of Data From Individual Patients in Randomized Controlled Trials. Gastroenterology. 157:462–471. DOI: 10.1053/j.gastro.2019.04.014. PMID: 30998991.

88. Leufkens AM, DeMarco DC, Rastogi A, et al. 2011; Effect of a retrograde-viewing device on adenoma detection rate during colonoscopy: the TERRACE study. Gastrointest Endosc. 73:480–489. DOI: 10.1016/j.gie.2010.09.004. PMID: 21067735.

89. Gralnek IM, Siersema PD, Halpern Z, et al. 2014; Standard forward-viewing colonoscopy versus full-spectrum endoscopy: an international, multicentre, randomised, tandem colonoscopy trial. Lancet Oncol. 15:353–360. DOI: 10.1016/S1470-2045(14)70020-8. PMID: 24560453. PMCID: PMC4062184.

90. Dik VK, Gralnek IM, Segol O, et al. 2015; Multicenter, randomized, tandem evaluation of EndoRings colonoscopy--results of the CLEVER study. Endoscopy. 47:1151–1158. DOI: 10.1055/s-0034-1392421. PMID: 26220283.

91. Wang P, Berzin TM, Glissen Brown JR, et al. 2019; Real-time automatic detection system increases colonoscopic polyp and adenoma detection rates: a prospective randomised controlled study. Gut. 68:1813–1819. DOI: 10.1136/gutjnl-2018-317500. PMID: 30814121. PMCID: PMC6839720.